Ghost Tree Capital as of Dec. 31, 2021
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 45 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 9.2 | $26M | 190k | 134.53 | |
| Apellis Pharmaceuticals (APLS) | 5.5 | $15M | 325k | 47.28 | |
| Cogent Biosciences (COGT) | 5.2 | $15M | 1.7M | 8.58 | |
| Celldex Therapeutics Com New (CLDX) | 4.8 | $14M | 350k | 38.64 | |
| Rapt Therapeutics (RAPT) | 4.6 | $13M | 350k | 36.73 | |
| Merus N V (MRUS) | 4.0 | $11M | 350k | 31.80 | |
| Bellus Health Com New | 3.9 | $11M | 1.3M | 8.05 | |
| Iveric Bio | 3.7 | $11M | 625k | 16.72 | |
| Miragen Therapeutics (VRDN) | 3.5 | $9.9M | 500k | 19.77 | |
| Iovance Biotherapeutics Call Option (IOVA) | 3.4 | $9.5M | 500k | 19.09 | |
| Rocket Pharmaceuticals (RCKT) | 3.3 | $9.3M | 425k | 21.83 | |
| Arvinas Ord (ARVN) | 3.2 | $9.0M | 110k | 82.14 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $9.0M | 100k | 90.05 | |
| Zentalis Pharmaceuticals (ZNTL) | 2.4 | $6.7M | 80k | 84.06 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $6.6M | 300k | 21.89 | |
| Vaxcyte (PCVX) | 2.1 | $5.9M | 250k | 23.79 | |
| Amicus Therapeutics (FOLD) | 2.1 | $5.8M | 500k | 11.55 | |
| Sierra Oncology Com New | 1.9 | $5.4M | 250k | 21.74 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $5.1M | 30k | 169.57 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.8 | $5.0M | 750k | 6.72 | |
| Aadi Bioscience (AADI) | 1.7 | $4.8M | 200k | 24.15 | |
| Aclaris Therapeutics (ACRS) | 1.7 | $4.7M | 325k | 14.54 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.7 | $4.6M | 210k | 22.10 | |
| Relmada Therapeutics (RLMD) | 1.6 | $4.5M | 200k | 22.53 | |
| Mirati Therapeutics | 1.6 | $4.4M | 30k | 146.70 | |
| Leap Therapeutics | 1.6 | $4.4M | 1.4M | 3.24 | |
| Kezar Life Sciences | 1.5 | $4.2M | 250k | 16.72 | |
| Satsuma Pharmaceuticals Ord | 1.5 | $4.1M | 904k | 4.50 | |
| Vistagen Therapeutics Com New | 1.4 | $3.9M | 2.0M | 1.95 | |
| Tarsus Pharmaceuticals (TARS) | 1.4 | $3.8M | 170k | 22.50 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.2 | $3.4M | 118k | 28.41 | |
| Pyxis Oncology Common Stock (PYXS) | 1.2 | $3.2M | 295k | 10.97 | |
| 9 Meters Biopharma | 1.1 | $3.2M | 3.3M | 0.98 | |
| Kura Oncology (KURA) | 1.1 | $3.2M | 225k | 14.00 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $3.1M | 100k | 31.24 | |
| Cti Biopharma | 1.1 | $3.0M | 1.2M | 2.48 | |
| Design Therapeutics (DSGN) | 1.0 | $2.9M | 135k | 21.41 | |
| Larimar Therapeutics (LRMR) | 0.9 | $2.4M | 225k | 10.79 | |
| Gh Research Ordinary Shares (GHRS) | 0.8 | $2.3M | 100k | 23.33 | |
| Global Blood Therapeutics In | 0.6 | $1.8M | 60k | 29.27 | |
| Immunic (IMUX) | 0.6 | $1.6M | 165k | 9.57 | |
| Reata Pharmaceuticals Cl A | 0.5 | $1.4M | 55k | 26.36 | |
| Aldeyra Therapeutics Call Option (ALDX) | 0.4 | $1.2M | 300k | 4.00 | |
| Pardes Biosciences | 0.3 | $819k | 50k | 16.38 | |
| Cabaletta Bio (CABA) | 0.2 | $512k | 135k | 3.79 |
